SHEZFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

$0.47+0.00%(+$0.00)

TickerSpark Score

53/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHEZF research report →

52-Week Range0% of range

Low $0.47

Current $0.47

High $0.72

Companywww.hepalink.com

Shenzhen Hepalink Pharmaceutical Group Co. , Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally.

CEO: Li Li
IPO: 2021
Employees: 1,926
HQ: Shenzhen, CN

Price Chart

+0.00% · this period

Valuation

Market Cap: $689.04M
P/E: 39.35
P/S: 2.35
P/B: 1.23
EV/EBITDA: 13.58
Div Yield: 2.45%

Profitability

Gross Margin: 33.54%
Op Margin: 12.27%
Net Margin: 7.03%
ROE: 3.12%
ROIC: 3.76%

Growth & Income

Revenue: $5.48B · 3.75%
Net Income: $349.49M · -45.96%
EPS: $0.24 · -45.45%
Op Income: $635.97M
FCF YoY: -20.06%

Performance & Tape

52W High: $0.72
52W Low: $0.47
50D MA: $0.47
200D MA: $0.47
Beta: 0.36
Avg Volume: 11.7

Get TickerSpark's AI analysis on SHEZF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime